Selected research
Industry Research
Furosemide Industry Research Report 2026
Market perspective
The global Furosemide market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Furosemide is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Furosemide is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Furosemide is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Furosemide include Sun Pharm Inds, Sandoz, Sanofi Aventis, Mylan, West-Ward Pharms, US Pharm Holdings, Ivax Sub Teva Pharms, Hospira and Emcure Pharms, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Furosemide market in terms of revenue (US$ million) and, where applicable, sales volume (tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Furosemide Market by Company
Sun Pharm Inds
Sandoz
Sanofi Aventis
Mylan
West-Ward Pharms
US Pharm Holdings
Ivax Sub Teva Pharms
Hospira
Emcure Pharms
Furosemide Segment by Type
Injection
Solution
Tablet
Furosemide Segment by Application
Clinics
Hospital
Pharmacy
Others
Furosemide Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Furosemide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Furosemide and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Furosemide.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Furosemide manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Furosemide by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Furosemide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Injection
- Solution
- Tablet
Applications
- Clinics
- Hospital
- Pharmacy
- Others
Companies covered
- Sun Pharm Inds
- Sandoz
- Sanofi Aventis
- Mylan
- West-Ward Pharms
- US Pharm Holdings
- Ivax Sub Teva Pharms
- Hospira
- Emcure Pharms
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Furosemide Market Size (2021-2032)
- 2.2.2 Global Furosemide Sales (2021-2032)
- 2.2.3 Global Furosemide Market Average Price (2021-2032)
- 2.3 Furosemide by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Injection
- 2.3.3 Solution
- 2.3.4 Tablet
- 2.4 Furosemide by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Clinics
- 2.4.3 Hospital
- 2.4.4 Pharmacy
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Furosemide Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Furosemide Sales (tons) of Manufacturers (2021-2026)
- 3.3 Global Furosemide Revenue of Manufacturers (2021-2026)
- 3.4 Global Furosemide Average Price by Manufacturers (2021-2026)
- 3.5 Global Furosemide Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Furosemide, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Furosemide, Product Type & Application
- 3.8 Global Manufacturers of Furosemide, Established Date
- 3.9 Global Furosemide Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sun Pharm Inds
- 4.1.1 Sun Pharm Inds Company Information
- 4.1.2 Sun Pharm Inds Business Overview
- 4.1.3 Sun Pharm Inds Furosemide Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sun Pharm Inds Furosemide Product Portfolio
- 4.1.5 Sun Pharm Inds Recent Developments
- 4.2 Sandoz
- 4.2.1 Sandoz Company Information
- 4.2.2 Sandoz Business Overview
- 4.2.3 Sandoz Furosemide Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sandoz Furosemide Product Portfolio
- 4.2.5 Sandoz Recent Developments
- 4.3 Sanofi Aventis
- 4.3.1 Sanofi Aventis Company Information
- 4.3.2 Sanofi Aventis Business Overview
- 4.3.3 Sanofi Aventis Furosemide Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Sanofi Aventis Furosemide Product Portfolio
- 4.3.5 Sanofi Aventis Recent Developments
- 4.4 Mylan
- 4.4.1 Mylan Company Information
- 4.4.2 Mylan Business Overview
- 4.4.3 Mylan Furosemide Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Mylan Furosemide Product Portfolio
- 4.4.5 Mylan Recent Developments
- 4.5 West-Ward Pharms
- 4.5.1 West-Ward Pharms Company Information
- 4.5.2 West-Ward Pharms Business Overview
- 4.5.3 West-Ward Pharms Furosemide Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 West-Ward Pharms Furosemide Product Portfolio
- 4.5.5 West-Ward Pharms Recent Developments
- 4.6 US Pharm Holdings
- 4.6.1 US Pharm Holdings Company Information
- 4.6.2 US Pharm Holdings Business Overview
- 4.6.3 US Pharm Holdings Furosemide Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 US Pharm Holdings Furosemide Product Portfolio
- 4.6.5 US Pharm Holdings Recent Developments
- 4.7 Ivax Sub Teva Pharms
- 4.7.1 Ivax Sub Teva Pharms Company Information
- 4.7.2 Ivax Sub Teva Pharms Business Overview
- 4.7.3 Ivax Sub Teva Pharms Furosemide Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Ivax Sub Teva Pharms Furosemide Product Portfolio
- 4.7.5 Ivax Sub Teva Pharms Recent Developments
- 4.8 Hospira
- 4.8.1 Hospira Company Information
- 4.8.2 Hospira Business Overview
- 4.8.3 Hospira Furosemide Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Hospira Furosemide Product Portfolio
- 4.8.5 Hospira Recent Developments
- 4.9 Emcure Pharms
- 4.9.1 Emcure Pharms Company Information
- 4.9.2 Emcure Pharms Business Overview
- 4.9.3 Emcure Pharms Furosemide Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Emcure Pharms Furosemide Product Portfolio
- 4.9.5 Emcure Pharms Recent Developments
5 Global Furosemide Market Scenario by Region
- 5.1 Global Furosemide Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Furosemide Sales by Region: 2021-2032
- 5.2.1 Global Furosemide Sales by Region: 2021-2026
- 5.2.2 Global Furosemide Sales by Region: 2027-2032
- 5.3 Global Furosemide Revenue by Region: 2021-2032
- 5.3.1 Global Furosemide Revenue by Region: 2021-2026
- 5.3.2 Global Furosemide Revenue by Region: 2027-2032
- 5.4 North America Furosemide Market Facts & Figures by Country
- 5.4.1 North America Furosemide Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Furosemide Sales by Country (2021-2032)
- 5.4.3 North America Furosemide Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Furosemide Market Facts & Figures by Country
- 5.5.1 Europe Furosemide Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Furosemide Sales by Country (2021-2032)
- 5.5.3 Europe Furosemide Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Furosemide Market Facts & Figures by Country
- 5.6.1 Asia Pacific Furosemide Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Furosemide Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Furosemide Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Furosemide Market Facts & Figures by Country
- 5.7.1 South America Furosemide Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Furosemide Sales by Country (2021-2032)
- 5.7.3 South America Furosemide Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Furosemide Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Furosemide Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Furosemide Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Furosemide Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Furosemide Sales by Type (2021-2032)
- 6.1.1 Global Furosemide Sales by Type (2021-2032) & (tons)
- 6.1.2 Global Furosemide Sales Market Share by Type (2021-2032)
- 6.2 Global Furosemide Revenue by Type (2021-2032)
- 6.2.1 Global Furosemide Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Furosemide Revenue Market Share by Type (2021-2032)
- 6.3 Global Furosemide Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Furosemide Sales by Application (2021-2032)
- 7.1.1 Global Furosemide Sales by Application (2021-2032) & (tons)
- 7.1.2 Global Furosemide Sales Market Share by Application (2021-2032)
- 7.2 Global Furosemide Revenue by Application (2021-2032)
- 7.2.1 Global Furosemide Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Furosemide Revenue Market Share by Application (2021-2032)
- 7.3 Global Furosemide Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Furosemide Value Chain Analysis
- 8.1.1 Furosemide Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Furosemide Production Mode & Process
- 8.2 Furosemide Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Furosemide Distributors
- 8.2.3 Furosemide Customers
9 Global Furosemide Analyzing Market Dynamics
- 9.1 Furosemide Industry Trends
- 9.2 Furosemide Industry Drivers
- 9.3 Furosemide Industry Opportunities and Challenges
- 9.4 Furosemide Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst